TrialScientific reports2026

Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial.

Taher Al-Tweigeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.